- Home
- Publications
- Publication Search
- Publication Details
Title
CD133, Selectively Targeting the Root of Cancer
Authors
Keywords
-
Journal
Toxins
Volume 8, Issue 6, Pages 165
Publisher
MDPI AG
Online
2016-05-30
DOI
10.3390/toxins8060165
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function
- (2016) D. A. Vallera et al. CLINICAL CANCER RESEARCH
- Enhanced ADCC and NK Cell Activation of an Anticarcinoma Bispecific Antibody by Genetic Insertion of a Modified IL-15 Cross-linker
- (2016) Joerg U Schmohl et al. MOLECULAR THERAPY
- Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM- Lung Cancer-Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis
- (2015) G. Bertolini et al. CANCER RESEARCH
- Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis
- (2015) Bin Wu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Targeting CD133high Colorectal Cancer Cells In Vitro and In Vivo With an Asymmetric Bispecific Antibody
- (2015) Lei Zhao et al. JOURNAL OF IMMUNOTHERAPY
- Preclinical targeting of human T-cell malignancies using CD4-specific chimeric antigen receptor (CAR)-engineered T cells
- (2015) K Pinz et al. LEUKEMIA
- HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
- (2015) Huimin Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Heterodimeric Bispecific Single Chain Variable Fragments (scFv) Killer Engagers (BiKEs) Enhance NK-cell Activity Against CD133+ Colorectal Cancer Cells
- (2015) J. U. Schmohl et al. Targeted Oncology
- Clinicopathological significance and prognostic value of the expression of the cancer stem cell marker CD133 in hepatocellular carcinoma: a meta-analysis
- (2015) Chen Zhong et al. TUMOR BIOLOGY
- Interleukin-15 in the treatment of cancer
- (2014) Thomas A Waldmann Expert Review of Clinical Immunology
- Going viral: chimeric antigen receptor T-cell therapy for hematological malignancies
- (2014) Saar Gill et al. IMMUNOLOGICAL REVIEWS
- Bispecific T-cell engagers for cancer immunotherapy
- (2014) Amelia M Huehls et al. IMMUNOLOGY AND CELL BIOLOGY
- Catumaxomab for the Treatment of Malignant Ascites in Patients With Chemotherapy-Refractory Ovarian Cancer
- (2014) Jonathan S. Berek et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Phase II Trial of the Anti-CD19 Bispecific T Cell–Engager Blinatumomab Shows Hematologic and Molecular Remissions in Patients With Relapsed or Refractory B-Precursor Acute Lymphoblastic Leukemia
- (2014) Max S. Topp et al. JOURNAL OF CLINICAL ONCOLOGY
- Interleukin 15 augments antitumor activity of cytokine gene-modified melanoma cell vaccines in a murine model
- (2014) Grzegorz Basak et al. ONCOLOGY REPORTS
- Identification of CD24 as a Cancer Stem Cell Marker in Human Nasopharyngeal Carcinoma
- (2014) Chun-Hung Yang et al. PLoS One
- A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia
- (2013) S. H. Petersdorf et al. BLOOD
- Evaluation of characteristics of CD44+CD117+ ovarian cancer stem cells in three dimensional basement membrane extract scaffold versus two dimensional monocultures
- (2013) Junsong Chen et al. BMC CELL BIOLOGY
- Heterodimeric Bispecific Single-Chain Variable-Fragment Antibodies Against EpCAM and CD16 Induce Effective Antibody-Dependent Cellular Cytotoxicity Against Human Carcinoma Cells
- (2013) Daniel A. Vallera et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- HER2 and Breast Cancer Stem Cells: More than Meets the Eye
- (2013) H. Korkaya et al. CANCER RESEARCH
- Cytokine-induced killer (CIK) cells bound with anti-CD3/anti-CD133 bispecific antibodies target CD133high cancer stem cells in vitro and in vivo
- (2013) Jianhua Huang et al. CLINICAL IMMUNOLOGY
- Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression
- (2013) Amy P.N. Skubitz et al. GYNECOLOGIC ONCOLOGY
- CD133 expression in circulating tumor cells from breast cancer patients: Potential role in resistance to chemotherapy
- (2013) Rosa Nadal et al. INTERNATIONAL JOURNAL OF CANCER
- CD133-targeted paclitaxel delivery inhibits local tumor recurrence in a mouse model of breast cancer
- (2013) Suresh Kumar Swaminathan et al. JOURNAL OF CONTROLLED RELEASE
- Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay
- (2013) Irène Baccelli et al. NATURE BIOTECHNOLOGY
- Developing Therapeutic Antibodies for Neurodegenerative Disease
- (2013) Y. Joy Yu et al. Neurotherapeutics
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
- (2013) Stephan A. Grupp et al. NEW ENGLAND JOURNAL OF MEDICINE
- A bispecific EpCAM/CD133-targeted toxin is effective against carcinoma
- (2013) Nate N. Waldron et al. Targeted Oncology
- TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction
- (2013) V Tirino et al. Cell Death & Disease
- The stem cell marker prominin-1/CD133 interacts with vascular endothelial growth factor and potentiates its action
- (2012) Avner Adini et al. ANGIOGENESIS
- Lung Cancer Stem Cells as a Target for Therapy
- (2012) Elieser Gorelik et al. Anti-Cancer Agents in Medicinal Chemistry
- RNA aptamers targeting cancer stem cell marker CD133
- (2012) Sarah Shigdar et al. CANCER LETTERS
- CD133: holy of grail of neuro-oncology or promiscuous red-herring?
- (2012) L. K. Donovan et al. CELL PROLIFERATION
- CD133 as a target for colon cancer
- (2012) Veronica Catalano et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Epithelial Cell Adhesion Molecule Regulates Tumor Initiation and Tumorigenesis via Activating Reprogramming Factors and Epithelial-Mesenchymal Transition Gene Expression in Colon Cancer
- (2012) Cheng-Wei Lin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Detailed Mammosphere Assay Protocol for the Quantification of Breast Stem Cell Activity
- (2012) Frances L. Shaw et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges
- (2012) Philipp Grosse-Gehling et al. JOURNAL OF PATHOLOGY
- CXCR4-Positive Subset of Glioma Is Enriched for Cancer Stem Cells
- (2012) Xuesheng Zheng et al. ONCOLOGY RESEARCH
- Regulation of CD133 by HDAC6 Promotes β-Catenin Signaling to Suppress Cancer Cell Differentiation
- (2012) Anthony B. Mak et al. Cell Reports
- Identification and characterization of a novel scFv recognizing human and mouse CD133
- (2012) Suresh Kumar Swaminathan et al. Drug Delivery and Translational Research
- Immunotoxin targeting CD133+ breast carcinoma cells
- (2012) John R. Ohlfest et al. Drug Delivery and Translational Research
- Clinical applications of aptamers and nucleic acid therapeutics in haematological malignancies
- (2011) Sarah Shigdar et al. BRITISH JOURNAL OF HAEMATOLOGY
- Calcium-binding protein S100P and cancer: mechanisms and clinical relevance
- (2011) Hongfei Jiang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Targeted Therapy With the T-Cell–Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free Survival
- (2011) Max S. Topp et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeted Inhibition of CD133+ Cells in Oral Cancer Cell Lines
- (2011) M. Damek-Poprawa et al. JOURNAL OF DENTAL RESEARCH
- Targeting Tumor-Initiating Cancer Cells with dCD133KDEL Shows Impressive Tumor Reductions in a Xenotransplant Model of Human Head and Neck Cancer
- (2011) N. N. Waldron et al. MOLECULAR CANCER THERAPEUTICS
- Unknown
- (2011) Ilya Ulasov et al. MOLECULAR MEDICINE
- MUC4 stabilizes HER2 expression and maintains the cancer stem cell population in ovarian cancer cells
- (2011) Moorthy P Ponnusamy et al. Journal of Ovarian Research
- Delivering cargoes into cancer cells using DNA aptamers targeting internalized surface portals
- (2010) Erik W. Orava et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- The AC133 Epitope, but not the CD133 Protein, Is Lost upon Cancer Stem Cell Differentiation
- (2010) K. Kemper et al. CANCER RESEARCH
- CD44posCD49fhiCD133/2hi Defines Xenograft-Initiating Cells in Estrogen Receptor–Negative Breast Cancer
- (2010) Matthew J. Meyer et al. CANCER RESEARCH
- EpCAM in carcinogenesis: the good, the bad or the ugly
- (2010) B. T. F. van der Gun et al. CARCINOGENESIS
- Identification of a novel monoclonal antibody recognizing CD133
- (2010) Suresh Kumar Swaminathan et al. JOURNAL OF IMMUNOLOGICAL METHODS
- CD133 suppresses neuroblastoma cell differentiation via signal pathway modification
- (2010) H Takenobu et al. ONCOGENE
- The Emerging Role of EpCAM in Cancer and Stem Cell Signaling
- (2009) M. Munz et al. CANCER RESEARCH
- Targeting CD133 antigen in cancer
- (2009) Gabriella Ferrandina et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Macromolecular drug transport into the brain using targeted therapy
- (2009) Jacek Lichota et al. JOURNAL OF NEUROCHEMISTRY
- Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells
- (2009) K. S. Chan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44
- (2009) Shigeo Takaishi et al. STEM CELLS
- CD133 as a Marker for Cancer Stem Cells: Progresses and Concerns
- (2009) Yaojiong Wu et al. STEM CELLS AND DEVELOPMENT
- Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas
- (2008) Heike Immervoll et al. BMC CANCER
- CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers
- (2008) L M Smith et al. BRITISH JOURNAL OF CANCER
- CD133 expression is an independent prognostic marker for low survival in colorectal cancer
- (2008) D Horst et al. BRITISH JOURNAL OF CANCER
- CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer
- (2008) S Maeda et al. BRITISH JOURNAL OF CANCER
- Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors
- (2008) S. Zhang et al. CANCER RESEARCH
- New Insights into the Cell Biology of Hematopoietic Progenitors by Studying Prominin-1 (CD133)
- (2008) Nicola Bauer et al. CELLS TISSUES ORGANS
- CD44 is of Functional Importance for Colorectal Cancer Stem Cells
- (2008) L. Du et al. CLINICAL CANCER RESEARCH
- Recent advances in cancer stem cells
- (2008) Robert W Cho et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Cancer Stem Cells: A Step Toward the Cure
- (2008) Bruce M. Boman et al. JOURNAL OF CLINICAL ONCOLOGY
- IL-15 trans-presentation promotes human NK cell development and differentiation in vivo
- (2008) Nicholas D. Huntington et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Stem Cell Marker CD133 (Prominin-1) Is Expressed in Various Human Glandular Epithelia
- (2008) Jana Karbanová et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation
- (2008) Liqin Zhu et al. NATURE
- Expression profiling of CD133+and CD133-epithelial cells from human prostate
- (2008) Christopher J. Shepherd et al. PROSTATE
- Tumor Regression in Cancer Patients by Very Low Doses of a T Cell-Engaging Antibody
- (2008) R. Bargou et al. SCIENCE
- The Stem Cell-Associated Antigen CD133 (Prominin-1) Is a Molecular Therapeutic Target for Metastatic Melanoma
- (2008) Germana Rappa et al. STEM CELLS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started